Relative Frequency of Blood-Borne Viruses in Hemodialysis-Dependent and Kidney Transplant Recipients in Iran
Background: Hemodialysis (HD) patients and kidney transplant (KT) recipients are exposed to be infected by blood-borne viruses (BBVs). Current study was conducted to evaluate the prevalence of BBVs in HD and KT patients in the whole Iranian population.
Methods: From Jan 2016 to Dec 2017, 174 hemodialysis and 139 kidney transplant recipients enrolled in this survey. After blood sampling, serum samples were detected for HBV, HCV, HCMV, HIV and HTLV antibodies. Seropositive samples confirmed by Polymerase chain reaction (PCR) method.
Results: Overall, 6 (3.44%) and 3 (2.15%) of hemodialysis-dependent and transplantation patients had evidence of HCV infection, whereas no patients were HIV and HBV positive, two cases (1.14%) of hemodialysis and one case (0.71%) of transplantation patients demonstrated the HTLV-1 infection. 52 (37.4%) of patients received graft were positive for HCMV antibody. In addition, our study showed a co-infection of HCMV with HCV (3 patients, 2.15%) in transplantation patients.
Conclusion: Prevalence of BBVs infection was lower in comparison to the previous studies. The current strict infection control practices in Iran appear to be effective in limiting dialysis and related infections after transplantation. Because BBVs infections constantly occur especially in dialysis and after transplantation units, our data will be useful to build a new strategic plan for the elimination of BBVs infection in kidney therapycenters.
Pirozzolo, J. J., & LeMay, D. C. (2007). Blood-borne infections. Clinics in sports medicine, 26(3), 425-431.
Davies, J., Jabbar, Z., Gagan, F., & Baird, R. W. (2012). Blood‐borne viruses in the haemodialysis‐dependent population attending Top End Northern Territory facilities 2000–2009. Nephrology, 17(5), 501-507.
Poorebrahim, M., Salarian, A., Najafi, S., Abazari, M. F., Aleagha, M. N., Dadras, M. N., ... & Poortahmasebi, V. (2017). Regulatory network analysis of Epstein-Barr virus identifies functional modules and hub genes involved in infectious mononucleosis. Archives of virology, 162(5), 1299-1309.
Abedi, F., Mozhgani, S. H., Rahimzadegan, M., Gudarzi, H., Valizadeh, N., & Rezaee, S. A. (2017). Prevalence and phylogenic study of human T-lymphotropic virus 1 in patients with thalassemia in the northeast of Iran. Future Virology, 12(5), 253-258.
Ajorloo, M., Bamdad, T., Hashempour, T., Alborzi, A. M., Mozhgani, S. H. R., Asadi, R., ... & Merat, S. (2015). Detection of Specific Antibodies to HCV-ARF/CORE+ 1 Protein in Cirrhotic and Non-Cirrhotic Patients with Hepatitis C: A Possible Association with Progressive Fibrosis. Archives of Iranian Medicine (AIM), 18(5).
Tavakoli, A., Moghoofei, M., Mostafaei, S., Ghaffari, H., Monavari, S. H., & Alavian, S. M. (2017). Prevalence of hepatitis B surface antigen among hemodialysis patients from Middle Eastern countries: a systematic review and meta-analysis. Future Virology, 12(6), 309-318.
Roushan, M. R. H., Farokhtabar, S., Bayani, M., & Siadati, S. (2016). Epidemiological aspects of hepatitis B and C and human immunodeficiency viruses among hemodialysis patients in Mazandaran Province, Iran. Nephro-urology monthly, 8(3).
Tokars, J. I., Arduino, M. J., & Alter, M. J. (2001). Infection control in hemodialysis units. Infectious disease clinics of North America, 15(3), 797-812.
Green, M. (2013). Introduction: infections in solid organ transplantation. American Journal of Transplantation, 13(s4), 3-8.
Zieliński, M., Tarasewicz, A., Zielińska, H., Jankowska, M., Moszkowska, G., Dębska-Ślizień, A., ... & Trzonkowski, P. (2016). CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients. Journal of Clinical Virology, 83, 17-25.
Zhang, S., Liu, L., Wang, R., Tuo, H., Guo, Y., Yi, L., ... & Wang, J. (2017). miR-138 promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through the SIRT1/p-STAT3 pathway. Archives of virology, 162(9), 2695-2704.
Khameneh, Z. R., Baradaran, M., & Sepehrvand, N. (2008). Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi Journal of Kidney Diseases and Transplantation, 19(5), 838.
Zhu, F., Yuan, J., Li, H. J., Zeng, Z. F., Luo, Z. W., Li, S. Q., ... & Liu, Y. M. (2016). Human cytomegalovirus UL49 encodes an early, virion-associated protein essential for virus growth in human foreskin fibroblasts. Archives of virology, 161(5), 1273-1284.
Morozov, V. A., Morozov, A. V., & Denner, J. (2016). New PCR diagnostic systems for the detection and quantification of porcine cytomegalovirus (PCMV). Archives of virology, 161(5), 1159-1168.
Zamani, F., Ameli, M., Razmjou, S., Shakeri, R., Amiri, A., & Darvish, R. (2010). Incidence of hepatitis C infection in patients on hemodialysis: a multicenter study of northern part of Iran. Saudi Journal of Kidney Diseases and Transplantation, 21(6), 1169.
Joukar, F., Mansour‐Ghanaei, F., Besharati, S., & Khosh‐Sorur, M. (2012). Occult hepatitis B infection in a hemodialysis population in Guilan province, northern Iran. Hemodialysis International, 16(2), 294-297.
Kalantari, H., Ebadi, S., Yaran, M., Maracy, M. R., & Shahshahan, Z. (2014). Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran. Advanced biomedical research, 3.
Zahedi, M. J., Moghaddam, S. D., Alavian, S. M., & Dalili, M. (2012). Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman Province, South-East Iran. Hepatitis monthly, 12(5), 339.
Aghakhani, A., Banifazl, M., Kalantar, E., Eslamifar, A., Ahmadi, F., Razeghi, E., ... & Ramezani, A. (2010). Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Therapeutic Apheresis and Dialysis, 14(3), 349-353.
Ghaffari, J., Ebrahimi, M., Makhlough, A., Mohammadjafari, H., & Nazari, Z. (2013). Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it?. Iranian journal of kidney diseases, 7(3), 187.
Ziyaeyan, M., & Behzadi, M. A. (2013). Hepatitis C virus load in seropositive liver and kidney transplant recipients by quantitative real-time PCR before and after transplantation. Jundishapur Journal of Microbiology, 6(8), 1-4.
Khameneh, Z. R., Sepehrvand, N., Masudi, S., & Taghizade-Afshari, A. (2010). Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp Clin Transplant, 8(2), 146-9.
Nasiri, S., Ahmadi, S. F., Lessan-Pezeshki, M., Seyfi, S., & Alatab, S. (2011, March). Lack of cytomegalovirus and polyomavirus coexistence in Iranian kidney transplant recipients. In Transplantation proceedings (Vol. 43, No. 2, pp. 536-539). Elsevier.
Kheirabad, A. K., Bahri, F., Kargar, M., & Ghasemzadeh, I. (2016). Hepatitis C and G Virus infection prevalence among hemodialysis patients and associated risk factors in the Hormozgan province of southern Iran. Hepatitis monthly, 16(10).
Bahri, F., Kheirabad, A. K., Ghasemzadeh, I., Shoja, S., & Gouklani, H. (2016). Hepatitis Viruses B and D and Human Immunodeficiency Virus infections in hemodialysis patients in the south of Iran: prevalence and genotypes. Hepatitis monthly, 16(1).
Somi, M. H., Etemadi, J., Ghojazadeh, M., Farhang, S., Faramarzi, M., Foroutan, S., & Soleimanpour, M. (2014). Risk factors of HCV seroconversion in hemodialysis patients in tabriz, iran. Hepatitis monthly, 14(6).
Etemadi, J., Somi, M. H., Ardalan, M. R., Hashemi, S. S. R., Soltani, G. G., & Shoja, M. M. (2012). Prevalence and risk factors of hepatitis B infection among hemodialysis patients in Tabriz: A multicenter report. Saudi Journal of Kidney Diseases and Transplantation, 23(3), 609.
Hamissi, J., & Hamissi, H. (2011). Occurrence of hepatitis B and C infection among hemodialyzed patients with chronic renal failure in Qazvin, Iran: A preliminary study. International Journal of Collaborative Research on Internal Medicine & Public Health, 3(1), 89.
Joukar, F., Besharati, S., Mirpour, H., & Mansour-Ghanaei, F. (2011). Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepatitis monthly, 11(3), 178.
Hassanshahi, G., Arababadi, M. K., Assar, S., Hakimi, H., Abedinzadeh, M., Rafatpanah, H., & Derakhshan, R. (2011). Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran. Archives of virology, 156(7), 1111-1115.
Azarpazhooh, M. R., Hasanpour, K., Ghanbari, M., Rezaee, S. R., Mashkani, B., Hedayati-Moghaddam, M. R., ... & Sahebari, M. (2012). Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS research and human retroviruses, 28(9), 1095-1101.
Rafatpanah, H., Hedayati-Moghaddam, M. R., Fathimoghadam, F., Bidkhori, H. R., Shamsian, S. K., Ahmadi, S., ... & Bazarbachi, A. (2011). High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. Journal of Clinical Virology, 52(3), 172-176.
Wang, Y. P., Huang, L. P., Du, W. J., Wei, Y. W., Xia, D. L., Wu, H. L., ... & Liu, C. M. (2016). The pseudorabies virus DNA polymerase processivity factor UL42 exists as a monomer in vitro and in vivo. Archives of virology, 161(4), 1027-1031.
Jafarian, M., Mozhgani, S. H., Patrad, E., Vaziri, H., Rezaee, S. A., Akbarin, M. M., & Norouzi, M. (2017). Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: A study of adult T cell leukemia malignancy associated with HTLV-1. Archives of virology, 162(4), 1009-1015.
Lee, J., & Kim, S. (2016). Regulation of CCAAT/enhancer-binding protein (C/EBP) α in human-cytomegalovirus-infected fibroblasts. Archives of virology, 161(5), 1151-1158.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.